ArticleAlzheimer's & dementia (New York, N. Y.)

ACE trial design: Equol targeting estrogen receptor-β in vascular and cognitive aging.

Akira Sekikawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.